<DOC>
	<DOCNO>NCT00847990</DOCNO>
	<brief_summary>The purpose study determine laboratory test develop Sequenom Center Molecular Medicine ( SCMM ) use new marker find mother 's blood well identify pregnancy child chromosome abnormality Down syndrome ( Trisomy 21 ) , Edwards syndrome ( Trisomy 18 ) , chromosome abnormality .</brief_summary>
	<brief_title>Non-Invasive Screening Fetal Aneuploidy</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<criteria>Subject willing provide write informed consent Pregnant female singleton gestation 18 year age old Subject agree provide 20 30 mL venous blood sample Subject one following : A ) currently schedule undergo amniocentesis and/or CVS procedure , OR B ) currently first trimester pregnancy plan undergo amniocentesis second trimester Subject receive result genetic analysis include evaluation fetus aneuploidy Subject lack capacity provide inform consent Twins , triplets multiple gestation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Down syndrome</keyword>
	<keyword>aneuploidy</keyword>
	<keyword>chromosome abnormality</keyword>
	<keyword>amniocentesis</keyword>
	<keyword>chorionic villus sample</keyword>
	<keyword>Laboratory Developed Test ( LDT )</keyword>
</DOC>